Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 36 of Fulcrum Therapeutics, Inc.'s SEC filings and found 3 warrant series, 1 ATM program, 2 shelf registrations and 1 completed offering on file for FULC. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NWBONorthwest Biotherapeutics, Inc.
IPSCCentury Therapeutics, Inc.
BIOABioAge Labs Inc.
NAUTNautilus Biotechnolgy, Inc.
LYELLyell Immunopharma, Inc.
ALECAlector, Inc.
LRMRLarimar Therapeutics, Inc.
QTTBQ32 Bio Inc.
LCTXLineage Cell Therapeutics, Inc.
PROKProKidney Corp.
LXEOLexeo Therapeutics, Inc. Common Stock
OCGNOcugen, Inc.
CAMPCAMP4 Therapeutics Corporation
FATEFate Therapeutics, Inc.
ABEOAbeona Therapeutics Inc.